FOI Request - Weight-loss Injections
Request -101004087596
Under the Freedom of Information (Scotland) Act 2002, please provide the following information held by your trading standards service for each calendar year 2023, 2024 and 2025:
1. The number of complaints or intelligence reports received about weight-loss injections or pens (for example semaglutide, tirzepatide, retatrutide, "GLP-1", Ozempic, Wegovy or Mounjaro), including counterfeit or unlicensed products.
2. Of these, the number where the seller or supplier was recorded as (a) a beauty salon or aesthetics clinic, (b) an online or social media seller, (c) a retail shop, (d) other or not recorded.
3. The number of seizures or detentions of such products, and the total number of units seized.
4. The number of cases referred to the Medicines and Healthcare products Regulatory Agency (MHRA).